In addition, another study on multiple myeloma patients revealed that MMP-2 and MMP-9 are secreted in higher amounts and are not balanced by inhibitors of TIMPs (Urbaniak-Kujda et al., 2016). This evidence concerns the gene MMP9 and AL amyloidosis.